BIOMAT Database Logo BIOMAT Database Logo

Pyridinolcarbamate in the long-term treatment of ischaemic heart disease. 1976

A Gulyás, and I Szám

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011727 Pyridinolcarbamate A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408) Pyricarbate,2,6-Pyridinedimethanol-bis-(N-methylcarbamate),Anginin,Angioxine,Colesterinex,Duaxol,Duvaline,Gasparol,Lisator,Movecil,P-23,Parmidine,Prodectin,Sospitan,P 23,P23
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Gulyás, and I Szám
THE EFFECT OF LONG-TERM HEPARIN TREATMENT IN ISCHAEMIC HEART DISEASE.
January 1965, Journal of atherosclerosis research,
A Gulyás, and I Szám
Ischaemic heart disease--the long term outlook.
July 1982, Public health,
A Gulyás, and I Szám
Long-term therapy of ischaemic heart disease.
October 1972, Arzneimittel-Forschung,
A Gulyás, and I Szám
[Pyridinolcarbamate treatment of ischemic heart disease].
January 1976, Vrachebnoe delo,
A Gulyás, and I Szám
LONG-TERM ANTI-COAGULANT THERAPY IN ISCHAEMIC HEART DISEASE.
November 1963, The Journal of the Association of Physicians of India,
A Gulyás, and I Szám
Serum lipids and lipoproteins in ischaemic heart disease following withdrawal of long-term metoprolol treatment.
January 1987, European journal of clinical pharmacology,
A Gulyás, and I Szám
Long-term prognosis following ventricular fibrillation in acute ischaemic heart disease.
October 1970, British medical journal,
A Gulyás, and I Szám
Long-term heparin treatment in ischaemic heart disease. Effects on clinical condition and plasma lipids.
August 1967, Acta medica Scandinavica,
A Gulyás, and I Szám
[Clinical results of pyridinolcarbamate treatment of chronic Chagas' heart disease].
March 1972, Revista brasileira de medicina,
A Gulyás, and I Szám
[Long-term ecg follow-up in diagnosing ischaemic heart disease (author's transl)].
April 1978, Casopis lekaru ceskych,
Copied contents to your clipboard!